Synchrony Partners With Sploot to Make Pet Healthcare More Affordable

Synchrony Financial (SYF) has partnered with Sploot Veterinary Care to integrate its CareCredit financing solution across Sploot clinics in key cities, enhancing access to pet healthcare amidst rising veterinary costs. This strategic collaboration bolsters SYF's embedded finance expansion efforts and positions it as a significant player in point-of-sale credit, despite a reported 3% year-over-year decline in active accounts in Q1 2025. The move comes as SYF shares have significantly outperformed the industry, gaining 44.2% over the past year.

Analysis

Synchrony Financial (SYF) is strategically expanding its embedded finance footprint through a new partnership with Sploot Veterinary Care, integrating its CareCredit financing solution into a growing, high-cost consumer sector. This collaboration taps into the rising demand for pet healthcare financing, driven by advancements in veterinary services, and leverages a seamless tech-enabled application process to enhance customer acquisition at the point of sale. While this move reinforces SYF's growth narrative and aligns with its strong stock performance, where shares gained 44.2% over the past year against an 11.6% industry average, a key counterpoint exists. The company reported a 3% year-over-year decrease in its average active accounts in the first quarter of 2025, suggesting potential headwinds in its broader portfolio that new partnerships aim to mitigate. The partnership with Sploot builds on CareCredit's established network of over 27,000 veterinary practices, solidifying SYF's market position despite the dip in overall account metrics.

Key Decisions for Investors

• Investors should view this partnership as a positive indicator of SYF's strategy to generate growth in resilient, non-discretionary spending categories like pet healthcare, which could support continued stock outperformance.
• It is crucial to monitor future earnings reports for a reversal in the trend of declining average active accounts, as the 3% drop indicates a potential vulnerability that targeted partnerships may not be sufficient to offset.
• Given the article's neutral 'Hold' rating for SYF and its highlight of 'Strong Buy' rated finance peers like Pagaya Technologies (PGY) and Heritage Insurance (HRTG), investors may consider evaluating SYF's risk/reward profile relative to these alternatives which exhibit strong upward earnings revisions.